Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia
- 1 February 2009
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 379 (2) , 542-546
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A‐V deficiency due to a novel mutation in the APOA5 geneJournal of Internal Medicine, 2008
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Apolipoprotein A-V Interaction with Members of the Low Density Lipoprotein Receptor Gene FamilyBiochemistry, 2007
- Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairmentJournal of Clinical Investigation, 2005
- Apolipoprotein A-V-heparin InteractionsJournal of Biological Chemistry, 2005
- Apolipoprotein AV Accelerates Plasma Hydrolysis of Triglyceriderich Lipoproteins by Interaction with Proteoglycan-bound Lipoprotein LipaseJournal of Biological Chemistry, 2005
- Inherited Apolipoprotein A-V Deficiency in Severe HypertriglyceridemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- ApoAV Reduces Plasma Triglycerides by Inhibiting Very Low Density Lipoprotein-Triglyceride (VLDL-TG) Production and Stimulating Lipoprotein Lipase-mediated VLDL-TG HydrolysisJournal of Biological Chemistry, 2004
- A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemiaHuman Molecular Genetics, 2003
- An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative SequencingScience, 2001